Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pocock

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of General Virology|October 24, 2003
Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4I S Yap, G Giddings, E Pocock, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1992
Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancyS M Kelsey, B Weinhardt, C E Pocock, et al.
Clinical Endocrinology|July 1, 1983
Plasma somatomedin activity and diabetic retinopathyI K Ashton, T L Dornan, A E Pocock, et al.
Cell Biology International|August 24, 1999
Expression of cation exchanger NHE and anion exchanger AE isoforms in primary human bone-derived osteoblastsA Mobasheri, S Golding, S N Pagakis, et al.
British Journal of Haematology|November 28, 2024
Quality of life in advanced-stage, asymptomatic, non-bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful-waitingMaria A V Marzolini, Wendi Qian, Laura Clifton-Hadley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II studyPeter Hillmen, John G Gribben, George A Follows, et al.
The Lancet. Oncology|March 8, 2014
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trialKirit M Ardeshna, Wendi Qian, Paul Smith, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of General Virology|October 24, 2003
Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4I S Yap, G Giddings, E Pocock, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1992
Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancyS M Kelsey, B Weinhardt, C E Pocock, et al.
Clinical Endocrinology|July 1, 1983
Plasma somatomedin activity and diabetic retinopathyI K Ashton, T L Dornan, A E Pocock, et al.
Cell Biology International|August 24, 1999
Expression of cation exchanger NHE and anion exchanger AE isoforms in primary human bone-derived osteoblastsA Mobasheri, S Golding, S N Pagakis, et al.
British Journal of Haematology|November 28, 2024
Quality of life in advanced-stage, asymptomatic, non-bulky follicular lymphoma treated with rituximab shows significant improvement compared with watchful-waitingMaria A V Marzolini, Wendi Qian, Laura Clifton-Hadley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II studyPeter Hillmen, John G Gribben, George A Follows, et al.
The Lancet. Oncology|March 8, 2014
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trialKirit M Ardeshna, Wendi Qian, Paul Smith, et al.
Pageof 2